XML 20 R2.htm IDEA: XBRL DOCUMENT v3.24.1
Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2023
Dec. 31, 2022
Current assets:    
Cash and cash equivalents $ 7,105 $ 11,009
Short-term investments 164,743 183,909
OMIDRIA contract royalty asset, short-term 29,373 28,797
Receivables 8,096 213,221
Prepaid expense and other assets 8,581 6,300
Total current assets 217,898 443,236
OMIDRIA contract royalty asset 138,736 123,425
Right of use assets 18,631 21,762
Property and equipment, net 1,950 1,492
Restricted investments 1,054 1,054
Total assets 378,269 590,969
Current liabilities:    
Accounts payable 7,712 5,989
Accrued expenses 31,868 30,551
Current portion of convertible senior notes, net 0 94,381
Current portion of OMIDRIA royalty obligation 8,576 1,152
Current portion of lease liabilities 5,160 4,310
Total current liabilities 53,316 136,383
Convertible senior notes, net 213,155 220,906
OMIDRIA royalty obligation 116,550 125,126
Lease liabilities, non-current 18,143 22,426
Other accrued liabilities - noncurrent 2,088 444
Commitments and contingencies (Note 10)
Shareholders’ equity (deficit):    
Preferred stock, par value $0.01 per share, 20,000,000 shares authorized; none issued and outstanding at December 31, 2023 and December 31, 2022 0 0
Common stock, par value $0.01 per share, 150,000,000 shares authorized at December 31, 2023 and December 31, 2022; 61,128,597 and 62,828,765 shares issued and outstanding at December 31, 2023 and December 31, 2022, respectively. 611 628
Additional paid-in capital 727,936 720,773
Accumulated deficit (753,530) (635,717)
Total shareholders’ equity (deficit) (24,983) 85,684
Total liabilities and shareholders’ equity (deficit) $ 378,269 $ 590,969